Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies ; volume:11 ; number:1 ; day:16 ; month:6 ; year:2020 ; pages:1-14 ; date:12.2020
Stem cell research & therapy ; 11, Heft 1 (16.6.2020), 1-14, 12.2020
- Creator
-
Shankar, Keerthana
Capitini, Christian M.
Saha, Krishanu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-020-01741-4
- URN
-
urn:nbn:de:101:1-2020081321254565874989
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shankar, Keerthana
- Capitini, Christian M.
- Saha, Krishanu
- SpringerLink (Online service)
Other Objects (12)
Pluripotent- and multipotent-stem cell derived hematopoietic cells and their use for regenerative therapies
Islet-like clusters derived from pluripotent stem cells (SC-islets) as mini organs for diabetes cell therapies
Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning
Microencapsulation-based cell therapies
Retrotransposons in pluripotent stem cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Cell therapies for pancreatic beta-cell replenishment
Cell-Based Therapies with T Regulatory Cells
Pluripotent- and multipotent-stem cell derived hematopoietic cells and their use for regenerative therapies
Islet-like clusters derived from pluripotent stem cells (SC-islets) as mini organs for diabetes cell therapies
Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning
Microencapsulation-based cell therapies
Retrotransposons in pluripotent stem cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Cell therapies for pancreatic beta-cell replenishment
Cell-Based Therapies with T Regulatory Cells
Pluripotent- and multipotent-stem cell derived hematopoietic cells and their use for regenerative therapies
Islet-like clusters derived from pluripotent stem cells (SC-islets) as mini organs for diabetes cell therapies
Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning
Microencapsulation-based cell therapies
Retrotransposons in pluripotent stem cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Cell therapies for pancreatic beta-cell replenishment